BAFNA PHARMACEUTICALS
Back to Balance Sheet
|
BAFNA PHARMACEUTICALS Last 5 Year Total Debt History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Debt | ₹28 Cr | ₹24 Cr | ₹23 Cr | ₹11 Cr | ₹13 Cr |
What is the latest Total Debt ratio of BAFNA PHARMACEUTICALS ?
| Year | Total Debt |
|---|---|
| Mar2025 | ₹28 Cr |
| Mar2024 | ₹24 Cr |
| Mar2023 | ₹23 Cr |
| Mar2022 | ₹11 Cr |
| Mar2021 | ₹13 Cr |
How is Total Debt of BAFNA PHARMACEUTICALS Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2025 | ₹28 Cr | 15.62 | |
| Mar2024 | ₹24 Cr | 6.39 | |
| Mar2023 | ₹23 Cr | 107.27 | |
| Mar2022 | ₹11 Cr | -14.92 | |
| Mar2021 | ₹13 Cr | - | |
Compare Total Debt of peers of BAFNA PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAFNA PHARMACEUTICALS | ₹366.9 Cr | 15.1% | 14.1% | 99.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹429,349.0 Cr | -3% | -1.9% | 7.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹174,543.0 Cr | -3.3% | -0.7% | -1.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹147,884.0 Cr | -3.8% | 2.8% | 36.4% | Stock Analytics | |
| CIPLA | ₹111,077.0 Cr | -3% | 3% | -6.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,388.0 Cr | -4.3% | -2% | 2.5% | Stock Analytics | |
BAFNA PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAFNA PHARMACEUTICALS | 15.1% |
14.1% |
99.3% |
| SENSEX | -2.2% |
-3.3% |
-8.8% |
You may also like the below Video Courses